PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) FOR NEWLY DIAGNOSED GLIOBLASTOMA

被引:0
作者
Ahluwalia, Manmeet [1 ]
Reardon, David [2 ]
Abad, Ajay [3 ]
Curry, William [4 ]
Wong, Eric [5 ]
Peereboom, David [1 ]
Belal, Ahmed [3 ]
Qiu, Jingxin [3 ]
Mogensen, Kathleen [3 ]
Schilero, Cathy [1 ]
Casucci, Danielle [3 ]
Mechtler, Laszlo [3 ]
Uhlmann, Erik [3 ]
Ciesielski, Michael [3 ]
Fenstermaker, Robert [3 ]
机构
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA
[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ATIM-41
引用
收藏
页码:10 / 11
页数:2
相关论文
共 50 条
[31]   PHASE I/IIA TRIAL OF AUTOLOGOUS FORMALIN-FIXED TUMOR VACCINE IN TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME [J].
Muragaki, Yoshihiro ;
Maruyama, Takashi ;
Iseki, Hiroshi ;
Takakura, Kintomo ;
Tanaka, Masahiko ;
Shinohara, Chie ;
Tsuboi, Koji ;
Yamamoto, Tetsuya ;
Matsumura, Akira ;
Matsutani, Masao ;
Karasawa, Katsuyuki ;
Ohno, Tadao ;
Hori, Tomokatsu .
NEURO-ONCOLOGY, 2009, 11 (06) :883-883
[32]   A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma [J].
Gilbert, Mark R. ;
Dignam, James J. ;
Armstrong, Terri S. ;
Wefel, Jeffrey S. ;
Blumenthal, Deborah T. ;
Vogelbaum, Michael A. ;
Colman, Howard ;
Chakravarti, Arnab ;
Pugh, Stephanie ;
Won, Minhee ;
Jeraj, Robert ;
Brown, Paul D. ;
Jaeckle, Kurt A. ;
Schiff, David ;
Stieber, Volker W. ;
Brachman, David G. ;
Werner-Wasik, Maria ;
Tremont-Lukats, Ivo W. ;
Sulman, Erik P. ;
Aldape, Kenneth D. ;
Curran, Walter J., Jr. ;
Mehta, Minesh P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (08) :699-708
[33]   A randomized trial of bevacizumab for newly diagnosed glioblastoma [J].
Schiff, David ;
Huse, Jason ;
Wen, Patrick .
NEURO-ONCOLOGY, 2014, 16 (06) :769-770
[34]   A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma [J].
Werlenius, Katja ;
Stragliotto, Giuseppe ;
Strandeus, Michael ;
Blomstrand, Malin ;
Caren, Helena ;
Jakola, Asgeir S. ;
Rydenhag, Bertil ;
Dyregaard, Dorte ;
Dzhandzhugazyan, Karine N. ;
Kirkin, Alexei F. ;
Raida, Martin K. ;
Smits, Anja ;
Kinhult, Sara .
NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
[35]   Phase II trial of copper depletion as angiosuppressive treatment in newly diagnosed Glioblastoma Multiforme: Final report. [J].
Brem, S ;
Grossman, SA ;
Carson, KA ;
New, P ;
Phuphanich, S ;
Alavi, JB ;
Mikkelsen, T ;
Priet, R .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :114S-114S
[36]   Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization [J].
Rahman, Rifaquat ;
Trippa, Lorenzo ;
Lee, Eudocia Q. ;
Arrillaga-Romany, Isabel ;
Fell, Geoffrey ;
Touat, Mehdi ;
McCluskey, Christine ;
Wiley, Jennifer ;
Gaffey, Sarah ;
Drappatz, Jan ;
Welch, Mary R. ;
Galanis, Evanthia ;
Ahluwalia, Manmeet S. ;
Colman, Howard ;
Nabors, L. Burt ;
Hepel, Jaroslaw ;
Elinzano, Heinrich ;
Schiff, David ;
Chukwueke, Ugonma N. ;
Beroukhim, Rameen ;
Nayak, Lakshmi ;
McFaline-Figueroa, J. Ricardo ;
Batchelor, Tracy T. ;
Rinne, Mikael L. ;
Kaley, Thomas J. ;
Lu-Emerson, Christine ;
Mellinghoff, Ingo K. ;
Bi, Wenya Linda ;
Arnaout, Omar ;
Peruzzi, Pier Paolo ;
Haas-Kogan, Daphne ;
Tanguturi, Shyam ;
Cagney, Daniel ;
Aizer, Ayal ;
Doherty, Lisa ;
Lavallee, Maria ;
Fisher-Longden, Brittany ;
Dowling, Shanna ;
Geduldig, Jack ;
Watkinson, Fiona ;
Pisano, William ;
Malinowski, Seth ;
Ramkissoon, Shakti ;
Santagata, Sandro ;
Meredith, David M. ;
Chiocca, E. Antonio ;
Reardon, David A. ;
Alexander, Brian M. ;
Ligon, Keith L. ;
Wen, Patrick Y. .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (36) :5524-+
[37]   Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: Pazoglio trial. [J].
Saada-Bouzid, Esma ;
Frenel, Jean-Sebastien ;
Augereau, Paule ;
Bourg, Veronique ;
Gal, Jocelyn ;
Jacquinot, Rique ;
Gourmelon, Carole ;
Chateau, Yann ;
Barriere, Jerome ;
Bondiau, Pierre-Yves .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[38]   MRI changes in patients with newly diagnosed glioblastoma treated as part a Phase II trial with bavituximab, radiation, and temozolomide [J].
Ly, Ina ;
Cardona, Jonathan ;
Beers, Andrew ;
Chang, Ken ;
Brown, James ;
Reardon, David ;
Arrillaga-Romany, Isabel ;
Dietrich, Jorg ;
Forst, Deborah ;
Lee, Eudocia ;
Jordan, Justin ;
Nayak, Lakshmi ;
Wen, Patrick ;
Batchelor, Tracy ;
Curry, William ;
Kalpathy-Cramer, Jayashree ;
Gerstner, Elizabeth .
NEUROLOGY, 2019, 92 (15)
[39]   PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA [J].
Glas, Martin ;
Scheffler, Bjoern ;
Lazaridis, Lazaros ;
Herrlinger, Ulrich ;
Pierscianek, Daniela ;
Sure, Ulrich ;
Proescholdt, Martin ;
Hau, Peter ;
Hense, Joerg ;
Kleinschnitz, Christoph ;
Grosu, Anca-Ligia ;
Stuschke, Martin ;
Kebir, Sied .
NEURO-ONCOLOGY, 2018, 20 :22-22
[40]   MRI CHANGES IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED AS PART OF A PHASE II TRIAL WITH BAVITUXIMAB, RADIATION, AND TEMOZOLOMIDE [J].
Ly, Ina ;
Cardona, Jonathan ;
Beers, Andrew ;
Chang, Ken ;
Brown, James ;
Reardon, David ;
Arrillaga-Romany, Isabel ;
Dietrich, Jorg ;
Forst, Deborah ;
Lee, Eudocia ;
Jordan, Justin ;
Nayak, Lakshmi ;
Wen, Patrick ;
Batchelor, Tracy ;
Kalpathy-Cramer, Jayashree ;
Gerstner, Elizabeth .
NEURO-ONCOLOGY, 2018, 20 :191-191